AETHLON MEDICAL (AEMD) Stock: Buy, Sell, or Hold?
AEMD - AETHLON MEDICAL INC
$6.97
5.54 (387.42%)
▲
5d:
+346.8%
30d:
+141.18%
90d:
+264.93%
WAIT
LOW Confidence
Analysis Updated: Sep 17, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When AEMD Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR BETTER ENTRY: AEMD is 100.3% above its trading range ($3.48). While momentum could continue, risk/reward favors waiting for a pullback.
⏸️ WAIT FOR BETTER ENTRY: AEMD is 100.3% above its trading range ($3.48). While momentum could continue, risk/reward favors waiting for a pullback.
In-depth Analysis How we analyze
Valuation Analysis: AEMD is currently trading at $6.97, which is considered extended relative to its 30-day fair value range of $1.41 to $3.48.
Technical Outlook: Technically, AEMD is in a uptrend. The price is approaching resistance at $2.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 387.4% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.25 (+826.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, AEMD is in a uptrend. The price is approaching resistance at $2.06. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 387.4% recently.
Market Sentiment: The stock scores a mixed 53/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $13.25 (+826.6%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$1.41 -
$3.48
Company Quality Score
50/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
45.8%
All Signals
- BEARISH: Price significantly overextended (+100.3% above its trading range)
- NEUTRAL: Mixed technical signals (53/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+387.4%)
- BULLISH: Trading 826.6% below Wall St target ($13.25)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$1.41 -
$3.48
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$1.41
Resistance Level
$2.06
Current Trend
Uptrend
Technical data as of
Sep 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.46
Wall Street Target
$13.25
(+826.6%)
Revenue Growth (YoY)
4278.2%
Share & Embed Analysis
Last updated: September 17, 2026 12:27 PM ET
Data refreshes hourly during market hours. Next update: 1:27 PM
Data refreshes hourly during market hours. Next update: 1:27 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is AEMD showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SYK
Stryker Corporation |
BUY
32 analysts |
$376 | 61 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$94 | 50 HOLD |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$120 | 54 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$101 | 60 BUY |
|
ZBH
Zimmer Biomet Holdings I… |
HOLD
29 analysts |
$108 | 64 BUY |
